Literature DB >> 2860118

Preliminary results of transmission experiments of non-A, non-B hepatitis by mononuclear leucocytes from a chronic patient.

J A Hellings, J van der Veen-du Prie, R Snelting-van Densen, R Stute.   

Abstract

Mononuclear leucocytes (mainly lymphocytes), isolated by Ficoll-Paque gradient centrifugation of blood freshly drawn from a haemophilia A patient with chronic non-A, non-B hepatitis (NANB), caused NANB when infused in a susceptible chimpanzee. Plasma from the same patient also transmitted the disease, as witnessed by elevated levels of liver enzymes in serum, histopathological signs of viral hepatitis and submicroscopic cytoplasmic alterations in the hepatocytes, considered to be specific for NANB in chimpanzees. In contrast, neither lymphocytes nor plasma from a chimpanzee apparently fully recovered from two episodes of NANB had the same effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860118     DOI: 10.1016/0166-0934(85)90048-5

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

Review 1.  Parenterally acquired non-A non-B hepatitis ten years on: advances in diagnosis and therapy.

Authors:  M R Jacyna; H C Thomas
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

2.  HCV-RNA assay in peripheral blood mononuclear cells in relation to IFN therapy.

Authors:  M Okuda
Journal:  Gastroenterol Jpn       Date:  1993-08

3.  Hepatitis C virus and peripheral blood mononuclear cell reservoirs Patricia Baré.

Authors:  Patricia Baré
Journal:  World J Hepatol       Date:  2009-10-31

4.  Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line.

Authors:  Y K Shimizu; A Iwamoto; M Hijikata; R H Purcell; H Yoshikura
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

5.  Hepatitis C virus activates Bcl-2 and MMP-2 expression through multiple cellular signaling pathways.

Authors:  Youxing Li; Qi Zhang; Yin Liu; Zhen Luo; Lei Kang; Jing Qu; Weiyong Liu; Xueshan Xia; Yingle Liu; Kailang Wu; Jianguo Wu
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.